HIV integraseR263A/K264A is defective for TRN-SR2/IN interaction and nuclear import of the PIC by De Houwer, Stéphanie et al.
174 HIV IntegraseR263A/K264A Is Defective for TRN-SR2/IN Interaction and Nuclear Import of the PIC
Stephanie Dehouwer, Jonas Demeulemeester, Wannes Thys, Zeger Debyser, Frauke Christ
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
Background: Transportin-SR2 (TRN-SR2/TNPO3) is a human karyopherin encoded by the TNPO3 gene. We identified TRN-SR2 as a binding partner of 
HIV-1 integrase (IN) and validated TRN-SR2 as an important cellular cofactor for the nuclear import of HIV-1. However, the question still remained whether 
the direct interaction between TRN-SR2 and IN mediates the nuclear import of HIV.
Methodology: By peptide screening we analyzed the interaction between TRN-SR2 and IN in molecular detail. Protein-protein interactions were verified 
by co-IP and AlphaScreen. We engineered site specific mutants in the C-terminal domain of HIV-1 IN that display reduced interaction with TRN-SR2 and 
studied their role in HIV replication using Q-PCR and fluorescence microscopy.
Results: Using the AlphaScreen protein-protein interaction assay we have been able to pinpoint the interacting hot spots in IN to R262/R263/K264 
and K266/R269 in the IN C-terminal domain. We also identified a secondary interaction surface involving residues F185/K186/R187 and K188 in the 
catalytic core domain. Next, we introduced mutations at these positions in the C-terminal domain in the virus to corroborate the biological relevance of the 
interaction. Several mutations in the C-terminal domain of HIV IN inhibited the IN/TRN-SR2 interaction and rendered the virus replication-deficient. Some 
mutants affected reverse transcription (RT) compromising analysis of HIV nuclear import. All mutants also affected integrase activity. Still, one mutant, 
INR263A/K264A, retained full RT activity but displayed a specific block at the level of nuclear import as measured by Q-PCR and fluorescence microscopy. 
Although this mutant was defective for integration, no increase in 2-LTR circles was detected. Moreover, HIV encoding INR263A/K264A showed reduced nuclear 
import when assayed with an eGFP-IN labeled HIV.
Conclusions: The INR263A/K264A mutation in the C-terminal domain of HIV-1 integrase reduces the interaction with TRN-SR2 and specifically blocks HIV 
replication at the stage of nuclear import, corroborating the importance of this direct protein-protein interaction in HIV nuclear import.
